Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ST-605 Phase 2 Open-label Study in Herpes Simplex Virus Keratitis
jRCT2080223845Phase 2Recruiting
- Sponsor
- M's Science Corporation
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ganciclovir in herpetic keratitis, sponsored by M's Science Corporation. Started Mar 2018; status: recruiting.
02
Drugs
ganciclovir
03
Conditions
herpetic keratitis
Beyond the preview
Go deeper on jRCT2080223845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223845.